Showing results (71-80 of 161) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumorsJosé Baselga, Andres Cervantes, Erika Martinelli, et al.
Cancers|April 30, 2021
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal CancerDavide Ciardiello, Giulia Martini, Vincenzo Famiglietti, et al.
Cancers|August 26, 2022
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941Davide Ciardiello, Giulia Martini, Vincenzo Famiglietti, et al.
American Journal of Clinical Oncology|February 8, 2006
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I studyChiara Carlomagno, Michele Orditura, Stefano Pepe, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 17, 2010
Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot studyMichele Orditura, Ferdinando De Vita, Paolo Muto, et al.
World Journal of Gastroenterology|August 3, 2017
Present and future of metastatic colorectal cancer treatment: A review of new candidate targetsGiulia Martini, Teresa Troiani, Claudia Cardone, et al.
Frontiers in Oncology|June 26, 2023
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lessonDavide Ciardiello, Sara Del Tufo, Paola Parente, et al.
Clinical Colorectal Cancer|July 6, 2021
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical DataPasquale Vitale, Nicoletta Zanaletti, Vincenzo Famiglietti, et al.
Cancer Investigation|May 21, 2010
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II studyMichele Orditura, Gennaro Galizia, Vincenzo Napolitano, et al.
Scientific Reports|October 20, 2020
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patientsEmilio Francesco Giunta, Giusi Barra, Vincenzo De Falco, et al.
Pageof 17